Company Profile

Akina Inc
Profile last edited on: 2/13/23      CAGE: 3ZDR8      UEI: WTBLC3LE13U1

Business Identifier: Controlled release, medicinal-delivery, and biomedical application
Year Founded
2001
First Award
2007
Latest Award
2014
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3495 Kent Avenue
West Lafayette, IN 47906
   (765) 464-0390
   info@akinainc.com
   www.akinainc.com
Location: Single
Congr. District: 04
County: Tippecanoe

Public Profile

Akina Inc is a biotechnology compnay developing new drug delivery technologies with the firm's premier product being a fast-melting, easy-to-swallow tablet The fast-melting tablet technology is currently available for delivery of nutraceuticals. Akina is divided into three divisions. The PolySciTech division distributes and synthesizes a variety of unique products to aid scientific research with an emphasis on providing hard-to-find materials in a format which is conducive to research. The Microparticle division conducts research in the field of microparticle drug delivery systems utilizing the hydrogel template technology and provides formulations and microparticle manufacturing devices for companies seeking novel drug delivery options. The Frosta division develops, manufactures and delivers fast-dissolving tablet formulations. In addition, the company also undertakes contracted analysis and development in the biomedical field.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
15-19

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2014 2 NIH $1,462,841
Project Title: Delayed Hydrogel Tissue Expander
2014 1 NIH $224,999
Project Title: IGF::OT::IGF
2014 1 NIH $208,489
Project Title: Tumor-Microenvironment-On-Chip of Breast Cancer
2011 1 NIH $100,001
Project Title: Intra-Oral Drug-Eluting Adhesive Film
2009 1 NIH $100,000
Project Title: Elastic Biodegradable Ureteral Stent

Key People / Management

  Kinam Park -- President

  Yourong Fu

  John Garner -- Manager

  Haesun Park

Company News

There are no news available.